Literature DB >> 12628064

Corticobasal Degeneration.

Panida Piboolnurak1, Cheryl H. Waters.   

Abstract

Corticobasal degeneration is one of the neurodegenerative tauopathies, which are defined as a group of heterogeneous dementias and movement disorders that are characterized neuropathologically by prominent intracellular accumulations of abnormal filaments formed by the microtubule-associated protein tau. Although there are no curative treatments, symptomatic and supportive management can be helpful. Many new therapies are still under development. However, more needs to be learned about the pathogenesis and molecular biology of this disease before an effective therapy can be developed.

Entities:  

Year:  2003        PMID: 12628064     DOI: 10.1007/s11940-003-0006-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  21 in total

Review 1.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.

Authors:  C Bergeron; M S Pollanen; L Weyer; A E Lang
Journal:  J Neuropathol Exp Neurol       Date:  1997-06       Impact factor: 3.685

Review 3.  Therapy and management of frontal lobe dementia patients.

Authors:  I Litvan
Journal:  Neurology       Date:  2001-06       Impact factor: 9.910

4.  Dystonia in corticobasal degeneration.

Authors:  Z Vanek; J Jankovic
Journal:  Mov Disord       Date:  2001-03       Impact factor: 10.338

Review 5.  [Exercices program and rehabilitation of motor disorders in Parkinson's disease].

Authors:  J Pélissier; D Pérennou
Journal:  Rev Neurol (Paris)       Date:  2000       Impact factor: 2.607

6.  Unusual clinical presentations of cortical-basal ganglionic degeneration.

Authors:  C Bergeron; M S Pollanen; L Weyer; S E Black; A E Lang
Journal:  Ann Neurol       Date:  1996-12       Impact factor: 10.422

Review 7.  Corticobasal degeneration.

Authors:  N P Stover; R L Watts
Journal:  Semin Neurol       Date:  2001       Impact factor: 3.420

8.  Phosphorylated neurofilament epitopes in the achromasic neurons of corticonigral degeneration.

Authors:  L N Wang; N W Kowall; E P Richardson
Journal:  Chin Med J (Engl)       Date:  1991-12       Impact factor: 2.628

9.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

10.  Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients.

Authors:  S McDowell; J Whyte; M D'Esposito
Journal:  Brain       Date:  1998-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.